QCIG
GILD icon

Quad-Cities Investment Group’s Gilead Sciences GILD Stock Holding History

Quad-Cities Investment Group’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-518
Closed -$33K – 368
2019
Q3 		$33K Buy
518
+69
+15% +$4.51K 0.03% 396
2019
Q2 		$30K Buy
449
+5
+1% +$329 0.03% 422
2019
Q1 		$29K Sell
444
-296
-40% -$19.7K 0.03% 423
2018
Q4 		$47K Buy
740
+4
+0.5% +$280 0.05% 328
2018
Q3 		$57K Buy
736
+3
+0.4% +$227 0.05% 327
2018
Q2 		$52K Buy
+733
New +$51.8K 0.05% 340

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Quad-Cities Investment Group's GILD Position: Q4 2019 in Review

Quad-Cities Investment Group sold out of Gilead Sciences (GILD) in Q4 2019, closing a stake of 518 shares — an estimated $33K sold.

Quad-Cities Investment Group first reported a position in GILD in Q2 2018 and held it in 6 quarters. The position peaked at $57K in Q3 2018. 1,555 funds tracked by Wall St. Rank hold GILD as of Q4 2019.

  • Quad-Cities Investment Group reported no remaining Gilead Sciences position as of Q4 2019 after selling out during the quarter.
  • Quad-Cities Investment Group sold 518 Gilead Sciences shares in Q4 2019, an estimated $33K.
  • Quad-Cities Investment Group first reported a position in Gilead Sciences in Q2 2018 and held it in 6 quarters.
  • Quad-Cities Investment Group's Gilead Sciences position peaked at $57K in Q3 2018.
  • 1,555 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2019.

Based on Quad-Cities Investment Group's 13F filing for Q4 2019, filed 28 Jan 2020.